177 related articles for article (PubMed ID: 28189595)
21. Genome-wide analyses of gene expression profile identify key genes and pathways involved in skeletal response to phosphate and 1,25-dihydroxyvitamin D
Lee SM; Meyer MB; Benkusky NA; Pike JW
J Steroid Biochem Mol Biol; 2023 Sep; 232():106335. PubMed ID: 37245694
[TBL] [Abstract][Full Text] [Related]
22. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
23. Neuropilin 2 in osteoblasts regulates trabecular bone mass in male mice.
Verlinden L; Doms S; Janssens I; Meyer MB; Pike JW; Carmeliet G; Verstuyf A
Front Endocrinol (Lausanne); 2023; 14():1223021. PubMed ID: 37600714
[TBL] [Abstract][Full Text] [Related]
24. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
25. Regulation of vitamin D-responsive gene expression by fluorinated analogs of calcitriol in rat osteoblastic ROB-C26 cells.
Miyamoto Y; Shinki T; Ohyama Y; Kasama T; Iwasaki H
J Biochem; 1995 Nov; 118(5):1068-76. PubMed ID: 8749328
[TBL] [Abstract][Full Text] [Related]
26. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.
Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM
J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117
[TBL] [Abstract][Full Text] [Related]
27. Primary human osteoblasts in response to 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3.
van der Meijden K; Lips P; van Driel M; Heijboer AC; Schulten EA; den Heijer M; Bravenboer N
PLoS One; 2014; 9(10):e110283. PubMed ID: 25329305
[TBL] [Abstract][Full Text] [Related]
28. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
Chen TL; Hauschka PV; Cabrales S; Feldman D
Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
[TBL] [Abstract][Full Text] [Related]
29. 24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells.
Curtis KM; Aenlle KK; Roos BA; Howard GA
Mol Endocrinol; 2014 May; 28(5):644-58. PubMed ID: 24597546
[TBL] [Abstract][Full Text] [Related]
30. 1,25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells.
Schlaeppi JM; Gutzwiller S; Finkenzeller G; Fournier B
Endocr Res; 1997 Aug; 23(3):213-29. PubMed ID: 9378108
[TBL] [Abstract][Full Text] [Related]
31. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.
Kigel B; Varshavsky A; Kessler O; Neufeld G
PLoS One; 2008 Sep; 3(9):e3287. PubMed ID: 18818766
[TBL] [Abstract][Full Text] [Related]
32. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.
Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC
J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029
[TBL] [Abstract][Full Text] [Related]
33. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
Veenstra TD; Fahnestock M; Kumar R
Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
[TBL] [Abstract][Full Text] [Related]
34. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.
Scharla SH; Strong DD; Mohan S; Baylink DJ; Linkhart TA
Endocrinology; 1991 Dec; 129(6):3139-46. PubMed ID: 1720089
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional regulation of the production of the third component of complement (C3) by 1 alpha,25-dihydroxyvitamin D3 in mouse marrow-derived stromal cells (ST2) and primary osteoblastic cells.
Hong MH; Jin CH; Sato T; Ishimi Y; Abe E; Suda T
Endocrinology; 1991 Nov; 129(5):2774-9. PubMed ID: 1935807
[TBL] [Abstract][Full Text] [Related]
36. The vitamin D receptor regulates miR-140-5p and targets the MAPK pathway in bone development.
Luo W; Liu L; Yang L; Dong Y; Liu T; Wei X; Liu D; Gu H; Kong J; Yuan Z; Zhao Q
Metabolism; 2018 Aug; 85():139-150. PubMed ID: 29604361
[TBL] [Abstract][Full Text] [Related]
37. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways.
Aghajanian H; Choi C; Ho VC; Gupta M; Singh MK; Epstein JA
J Biol Chem; 2014 Jun; 289(26):17971-9. PubMed ID: 24825896
[TBL] [Abstract][Full Text] [Related]
38. Effects of diastereoisomers of 1,25-dihydroxyvitamin D3-26,23-lactone on alkaline phosphatase and collagen synthesis in osteoblastic cells.
Ishizuka S; Kiyoki M; Kurihara N; Hakeda Y; Ikeda K; Kumegawa M; Norman AW
Mol Cell Endocrinol; 1988 Jan; 55(1):77-86. PubMed ID: 2834243
[TBL] [Abstract][Full Text] [Related]
39. Effect of 1,25-dihydroxyvitamin D3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes.
Kanatani M; Sugimoto T; Fukase M; Chihara K
Biochem Biophys Res Commun; 1993 Jan; 190(2):529-35. PubMed ID: 8427595
[TBL] [Abstract][Full Text] [Related]
40. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription.
Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
